An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity
CARDIOCARE participated in the ESMO Congress 2022 with a poster presentation entitled “Incorporating psycho-social factors in cancer treatment adverse events studies“. Really glad to have participated!
https://www.annalsofoncology.org/article/S0923-7534(22)03386-5/fulltext
Highlights
At the CARDIO2026 Congress held in Athens on 18–19 May, the CARDIOCARE project made a strong scientific contribution with a dedicated session showcasing its latest advances in cardio-oncology and patient-centered risk prediction. The special session, titled “From...
On 28 May 2026, the CARDIOCARE consortium successfully hosted the CARDIOCARE Workshop at the Thon Hotel EU in Brussels, bringing together researchers, clinicians, healthcare professionals, policymakers, project partners, and stakeholders from across Europe. The...
Innovative AI, digital health tools, and novel biomarkers are helping advance personalised cardio-oncology care for older breast cancer patients across Europe. The CARDIOCARE project is proud to announce a significant milestone in its mission to improve cardiovascular...